文献速递腹部介入CTMR

肝细胞癌立体定向体部放疗后的影像学评估

Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment.
PubMed 文献 · Br J Radiol · 2018-02-01

本文为图文综述,介绍肝细胞癌立体定向体部放疗(SBRT)技术基础,概述治疗后肿瘤反应的预期横断面影像表现,并重点讨论判读中的潜在陷阱及常见放射性并发症。

要点

  • SBRT是用于不可切除原发性肝恶性肿瘤及肝转移瘤的非侵入性局部治疗。
  • 熟悉SBRT后肝实质的预期表现、潜在陷阱与并发症,对准确评估治疗反应至关重要。
  • 本文图文并茂地描述了SBRT技术、肿瘤反应的横断面影像表现及判读陷阱。

核心结论

  • 熟悉SBRT后肝脏的预期影像表现、潜在判读陷阱与并发症,是准确评估肝细胞癌治疗反应的关键。

研究设计与样本

  • 图文综述,提供SBRT技术的基本描述,概述肿瘤反应的预期横断面影像表现,并回顾SBRT后肝实质改变及常见放射性并发症。

关键影像表现/征象

  • SBRT后肝脏可出现预期的肝实质改变。
  • SBRT后可出现放射性并发症,文中回顾了部分常见类型。

临床应用与阅片要点

  • 熟悉SBRT后肝脏的预期影像表现,有助于准确评估治疗反应。
  • 判读时需注意潜在陷阱与并发症,以避免误判。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Surgical resection, when feasible, is the standard of care for hepatocellular carcinoma. However, many tumours are not resectable at the time of diagnosis. Recently, stereotactic body radiation therapy (SBRT) has emerged as a non-invasive local therapy for both non-resectable primary hepatic malignancies as well as hepatic metastases. Knowledge of the expected hepatic parenchymal appearance post treatment, as well as potential pitfalls and complications, is essential for accurate evaluation of treatment response. This pictorial review provides a fundamental description of the SBRT technique, outlines the expected cross-sectional imaging appearances of tumour response, and highlights potential pitfalls in interpretation. The expected liver parenchymal changes post-SBRT are also reviewed, along with some common radiation-induced complications.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Kellock T, Liang T, Harris A, et al. Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment. Br J Radiol. 2018. PMID: 29334232. doi:10.1259/bjr.20170118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。